169 related articles for article (PubMed ID: 21539305)
1. New C15-substituted active vitamin D3.
Shindo K; Kumagai G; Takano M; Sawada D; Saito N; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Ishizuka S; Takenouchi K; Kittaka A
Org Lett; 2011 Jun; 13(11):2852-5. PubMed ID: 21539305
[TBL] [Abstract][Full Text] [Related]
2. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
[TBL] [Abstract][Full Text] [Related]
3. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
Arai MA; Kittaka A
Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of 2α-(tetrazolylethyl)-1α,25-dihydroxyvitamin D3 as a high affinity ligand for vitamin D receptor.
Matsuo M; Hasegawa A; Takano M; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Takenouchi K; Sawada D; Kittaka A
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():201-3. PubMed ID: 24036313
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric catalytic ene-cyclization approach to 2-fluoro-19-nor-1,25-dihydroxyvitamin D(3) A-ring analog with significant transactivation activity.
Mikami K; Ohba S; Ohmura H; Kubodera N; Nakagawa K; Okano T
Chirality; 2001 Jul; 13(7):366-71. PubMed ID: 11400190
[TBL] [Abstract][Full Text] [Related]
8. 2-Methylene analogs of 1alpha-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor.
Grzywacz P; Plum LA; Sicinska W; Sicinski RR; Prahl JM; DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):13-7. PubMed ID: 15225739
[TBL] [Abstract][Full Text] [Related]
9. New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis.
Glebocka A; Sicinski RR; DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):25-30. PubMed ID: 15225741
[TBL] [Abstract][Full Text] [Related]
10. Functionalization at C-12 of 1alpha,25-dihydroxyvitamin D(3) strongly modulates the affinity for the vitamin D receptor (VDR).
González-Avión XC; Mouriño A
Org Lett; 2003 Jun; 5(13):2291-3. PubMed ID: 12816431
[TBL] [Abstract][Full Text] [Related]
11. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
[TBL] [Abstract][Full Text] [Related]
12. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
[TBL] [Abstract][Full Text] [Related]
13. An analog of 1alpha,25-dihydroxy-19-norvitamin D3 with the 1alpha-hydroxy group fixed in the axial position lacks biological activity in vitro.
Sicinski RR; Glebocka A; Plum LA; DeLuca HF
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):293-7. PubMed ID: 17223547
[TBL] [Abstract][Full Text] [Related]
14. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
[TBL] [Abstract][Full Text] [Related]
15. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
[TBL] [Abstract][Full Text] [Related]
16. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
[TBL] [Abstract][Full Text] [Related]
17. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
[TBL] [Abstract][Full Text] [Related]
18. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations.
Vanhooke JL; Tadi BP; Benning MM; Plum LA; DeLuca HF
Arch Biochem Biophys; 2007 Apr; 460(2):161-5. PubMed ID: 17227670
[TBL] [Abstract][Full Text] [Related]
19. Highly potent vitamin D receptor antagonists: design, synthesis, and biological evaluation.
Saito N; Kittaka A
Chembiochem; 2006 Oct; 7(10):1479-90. PubMed ID: 16871612
[TBL] [Abstract][Full Text] [Related]
20. C15-functionalized 16-ene-1α,25-dihydroxyvitamin D3 is a new vitamin D analog with unique biological properties.
Kumagai G; Takano M; Shindo K; Sawada D; Saito N; Saito H; Kakuda S; Takagi K; Takimoto-Kamimura M; Takenouchi K; Chen TC; Kittaka A
Anticancer Res; 2012 Jan; 32(1):311-7. PubMed ID: 22213321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
